OAKLAND, California, Feb. 1 /PRNewswire-FirstCall/ -- World Heart Corporation (“WorldHeart” or the “Company”) will hold a conference call open to all interested parties on Thursday, February 3, 2005 at 10:30 am (EST) hosted by Jal S. Jassawalla, President and CEO, and Mark Goudie, Vice President Finance and Chief Financial Officer, to discuss its recently announced purchase of MedQuest Products, Inc.
The teleconference can be accessed by calling 1-800-814-4890. Please dial in ten to fifteen minutes prior to the beginning of the call. A replay of the conference call will be available through February 17, 2005 starting at 1:30 pm (EST) on February 3, 2005. The recording can be accessed at 1-877-289-8525 and entering passcode 21111964(pound key).
About World Heart Corporation
World Heart Corporation, a worldwide pioneer and technology leader in mechanical circulatory support systems, is a global medical device company with offices in Oakland, California, USA, Heesch, Netherlands, and Ottawa, Ontario, Canada. WorldHeart is currently focused on the development and commercialization of ventricular assist devices. Its Novacor(R) LVAS, which has unprecedented reliability and durability, is well established in the marketplace. It is the first ventricular assist device to provide a recipient with more than 6 years of circulatory support and continues to hold the industry record for longest support on a single device, over 4.5 years. To date, close to 1,600 patients have been supported with the Novacor, with more than 600 patient years of experience, and no deaths attributable to device failure. Its next-generation pulsatile technology (the Novacor II) is a miniaturized implantable assist device building on the proven Novacor technology.
WORLD HEART CORPORATION
CONTACT: Peggy Allman, World Heart Corporation, (510) 563-4721,http://www.worldheart.com/